[BAUTO] QoQ Annualized Quarter Result on 31-Jul-2020 [#1]

Stock
[BAUTO] BERMAZ AUTO BERHAD
Announcement Date
10-Sep-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Apr-2021
Quarter
31-Jul-2020 [#1]
Profit Trend
QoQ- -63.21%
YoY- -81.7%
Quarter Report
Latest QR
Upcoming QR
BAUTO's Result
BAUTO's Financial Summary
View:
Show?
Annualized Quarter Result
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
Revenue 2,287,915 2,195,624 2,097,476 1,795,576 1,759,036 1,946,234 1,984,426 9.96%
PBT 172,693 118,964 94,030 52,460 131,771 171,429 188,450 -5.65%
Tax -41,134 -31,378 -27,790 -18,112 -28,252 -36,145 -42,288 -1.82%
NP 131,559 87,585 66,240 34,348 103,519 135,284 146,162 -6.78%
-
NP to SH 133,944 89,489 68,070 36,980 100,512 130,737 141,806 -3.73%
-
Tax Rate 23.82% 26.38% 29.55% 34.53% 21.44% 21.08% 22.44% -
Total Cost 2,156,356 2,108,038 2,031,236 1,761,228 1,655,517 1,810,950 1,838,264 11.23%
-
Net Worth 567,125 516,480 499,833 480,910 469,636 478,277 483,207 11.27%
Dividend
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
Div 75,492 50,327 40,674 23,243 86,582 115,368 139,253 -33.53%
Div Payout % 56.36% 56.24% 59.75% 62.85% 86.14% 88.24% 98.20% -
Equity
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
Net Worth 567,125 516,480 499,833 480,910 469,636 478,277 483,207 11.27%
NOSH 1,163,927 1,163,927 1,163,549 1,163,549 1,163,549 1,163,538 1,160,441 0.20%
Ratio Analysis
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
NP Margin 5.75% 3.99% 3.16% 1.91% 5.88% 6.95% 7.37% -
ROE 23.62% 17.33% 13.62% 7.69% 21.40% 27.34% 29.35% -
Per Share
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
RPS 196.99 189.05 180.49 154.50 151.36 167.57 171.01 9.89%
EPS 11.53 7.71 5.86 3.20 8.65 11.25 12.22 -3.80%
DPS 6.50 4.33 3.50 2.00 7.45 9.93 12.00 -33.57%
NAPS 0.4883 0.4447 0.4301 0.4138 0.4041 0.4118 0.4164 11.21%
Adjusted Per Share Value based on latest NOSH - 1,163,549
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
RPS 195.39 187.51 179.13 153.35 150.23 166.21 169.47 9.96%
EPS 11.44 7.64 5.81 3.16 8.58 11.17 12.11 -3.72%
DPS 6.45 4.30 3.47 1.99 7.39 9.85 11.89 -33.50%
NAPS 0.4843 0.4411 0.4269 0.4107 0.4011 0.4085 0.4127 11.26%
Price Multiplier on Financial Quarter End Date
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
Date 30/04/21 29/01/21 30/10/20 30/07/20 30/04/20 31/01/20 31/10/19 -
Price 1.48 1.36 1.16 1.41 1.36 1.85 2.28 -
P/RPS 0.75 0.72 0.64 0.91 0.90 1.10 1.33 -31.76%
P/EPS 12.83 17.65 19.80 44.31 15.73 16.43 18.66 -22.11%
EY 7.79 5.67 5.05 2.26 6.36 6.08 5.36 28.33%
DY 4.39 3.19 3.02 1.42 5.48 5.37 5.26 -11.36%
P/NAPS 3.03 3.06 2.70 3.41 3.37 4.49 5.48 -32.65%
Price Multiplier on Announcement Date
30/04/21 31/01/21 31/10/20 31/07/20 30/04/20 31/01/20 31/10/19 CAGR
Date 18/06/21 10/03/21 10/12/20 10/09/20 11/06/20 16/03/20 10/12/19 -
Price 1.48 1.35 1.50 1.41 1.62 1.48 2.15 -
P/RPS 0.75 0.71 0.83 0.91 1.07 0.88 1.26 -29.26%
P/EPS 12.83 17.52 25.61 44.31 18.73 13.15 17.59 -18.98%
EY 7.79 5.71 3.90 2.26 5.34 7.61 5.68 23.46%
DY 4.39 3.21 2.33 1.42 4.60 6.71 5.58 -14.79%
P/NAPS 3.03 3.04 3.49 3.41 4.01 3.59 5.16 -29.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment